CLINICAL_TRIALS
withdrawal
· 2016-03-03
Clinical Trial Update: A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds [Phase 4]
Summary
Phase 4 randomized trial comparing AmnioClear human allograft amniotic membrane to moist wound dressing for diabetic foot ulcers has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Liventa Bioscience | Conditions: Diabetic Foot Ulcers, Wound Care | Phase 4 | Status: WITHDRAWN